FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084633 [Registered on: 11/04/2025] Trial Registered Prospectively
Last Modified On: 05/05/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To study pain relief in children after tonsillectomy by giving Levobupivacaine with Dexmedetomidine or Dexamethasone locally around tonsils.  
Scientific Title of Study   Comparative study between Levobupivacaine Plus Dexmedetomidine versus Levobupivacaine plus Dexamethasone Infiltration for Post-Tonsillectomy Analgesia  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sumedha Mehta 
Designation  Professor 
Affiliation  Smt kashibai Navale medical College and General Hospital 
Address  Department of Anesthesia, SKNMC and GH Narhe Pune

Pune
MAHARASHTRA
411041
India 
Phone  9923091187  
Fax    
Email  drsumedhamehta1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sumedha Mehta 
Designation  Professor 
Affiliation  Smt kashibai Navale medical College and General Hospital 
Address  Department of Anesthesaia 3 rd Floor, SKNMC and GH, Narhe, Pune

Pune
MAHARASHTRA
411041
India 
Phone  9923091187  
Fax    
Email  drsumedhamehta1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sumedha Mehta 
Designation  Professor 
Affiliation  Smt kashibai Navale medical College and General Hospital 
Address  Department of Anesthesia 3 rd floor, SKNMC and GH, Narhe, Pune 411041

Pune
MAHARASHTRA
411041
India 
Phone  9923091187  
Fax    
Email  drsumedhamehta1@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology Smt. Kashibai Navale Medical College General Hospital Narhe Pune Maharashtra India 411041 
 
Primary Sponsor  
Name  Dr Sumedha Mehta 
Address  Department of Anaesthesiology Smt. Kashibai Navale Medical College General Hospital 
Type of Sponsor  Other [Dr Sumedha Mehta] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Ankita Patil  Department of Anaesthesiology Smt. Kashibai Navale Medical College General Hospital 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sumedha Mehta  Smt kashibai Navale Medical College and General Hospital,Pune   Department of Anesthesia,3rd Floor, SKNMC and GH Narhe Pune MAHARASHTRA
Pune
MAHARASHTRA 
9923091187

drsumedhamehta1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Smt Kashibai Navale Medical college and General hospital Institutional Ethics Committee.   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Enlarged Tonsils 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Levobupivacaine 0.25% 2.5ml plus Dexamethasone 0.25mg/kg will be given only once before tonsilar surgery for analgesia.  Peritonsillar fossa will be infiltrated with Levobupivacaine 0.25% 2.5ml plus Dexamethasone 0.25mg/kg before starting surgery. 
Intervention  Levobupivacaine 0.25% 2.5ml plus dexmedetomidine 1mcg/kg only once before surgery for analgesia.  Peritonsillar fossa will be infiltrated with Levobupivacaine 0.25% 2.5ml plus dexmedetomidine 1mcg/kg before starting the surgery. 
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Physical status ASA 1 and 2. 
 
ExclusionCriteria 
Details  Refusal for participation
Inadequate NBM
Bleeding disorder, Active Upper respiratory infection, Emergency surgery. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of postoperative analgesia from start of peritonsillar infiltration with study drug till first rescue analgesia given at when CHEOPS score is more than 5 or Wong Baker pain scale more than 4 postoperatively.  Time from peritonsillar infiltration of study drugs till first rescue analgesia given postoperatively.Total number of Analgesia in 24hrs postopertively. 
 
Secondary Outcome  
Outcome  TimePoints 
1) Total number of rescue analgesic dosages consumed in 24 hours postoperatively.
2) For the first 24 hours after surgery, the total oral intake (fluids and semisolids).
3) Perioperative side effects: such as hypotension, hypertension,
tachycardia, bradycardia, hypoxia, arrhythmia, excessive secretions, bleeding, respiratory depression, nausea,
and vomiting will be noted.4) Ramsay sedation scale.5) CHEOPS score and VAS score postoperatively. 
From the time of study drug administration till 24hrs postoperatively.  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   21/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   We want to do the study to compare the intraoperative and postoperative analgesic effects of peritonsillar infiltration of Levobupivacaine 0.25% with either dexmedetomidine or dexamethasone in pediatric patients undergoing elective tonsillectomy. 
Close